Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Prostate Cancer and Prostatic Diseases
|
February 12, 2014
Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners
G Ploussard, N Nicolaiew, P Mongiat-Artus, et al.
The American Journal of Surgical Pathology
|
June 23, 2001
Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution
Y Allory, D Challine, C Haioun, et al.
Prostate Cancer and Prostatic Diseases
|
September 19, 2007
Invasion of bladder neck after radical prostatectomy: one definition for different outcomes
F Rodriguez-Covarrubias, S Larré, M Dahan, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 16, 2000
Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology
S Deleu, Y Allory, A Radulescu, et al.
Prostate Cancer and Prostatic Diseases
|
November 26, 2009
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
G Ploussard, B Paule, L Salomon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)
Y Neuzillet, B Pradère, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC)
Y Neuzillet, T Seisen, O Traxer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC)
Y Neuzillet, F Audenet, Y Loriot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 13, 2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]
P Leon, F Saint, F Audenet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2024
Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
C S Groeneveld, C Pfister, S Culine, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Prostate Cancer and Prostatic Diseases
|
February 12, 2014
Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners
G Ploussard, N Nicolaiew, P Mongiat-Artus, et al.
The American Journal of Surgical Pathology
|
June 23, 2001
Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution
Y Allory, D Challine, C Haioun, et al.
Prostate Cancer and Prostatic Diseases
|
September 19, 2007
Invasion of bladder neck after radical prostatectomy: one definition for different outcomes
F Rodriguez-Covarrubias, S Larré, M Dahan, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 16, 2000
Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology
S Deleu, Y Allory, A Radulescu, et al.
Prostate Cancer and Prostatic Diseases
|
November 26, 2009
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
G Ploussard, B Paule, L Salomon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)
Y Neuzillet, B Pradère, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC)
Y Neuzillet, T Seisen, O Traxer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC)
Y Neuzillet, F Audenet, Y Loriot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 13, 2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]
P Leon, F Saint, F Audenet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2024
Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
C S Groeneveld, C Pfister, S Culine, et al.
Page
of 5